¿Cual Es La Estrategia Del Paquete Para Los Hombres?
La estrategia del paquete para los hombres consiste en tres productos
separados sinérgicos
los cuales, cuando se toman juntos ayudan al cuerpo a normalizar la función
hormonal dentro del sistema endocrinal masculino. Cada paquete estrategia
para hombres consiste en una botella de Endocrina para hombres, una botella
de Eternal-In y una de Prostatin+. Todas son formulas medicinales homeopáticas
las que sinergeticamente ayudan al cuerpo naturalmente a curarse y regenerarse a si mismo.
Cada Paquete De estrategia Para Los Hombres contiene: 1 botella
de Prostatin+, 1 botella Eternal-In para hombres, y 1 botella de Endocrin para
hombres de 60 cápsulas por botella.. |
Trate Men's Strategy Pac - discontinued Hoy sin riesgo alguno con Växa
por 30 días o le regresamos su dinero
Men’s Strategy Pac $93.95
|
Selected References:
Azuma, Tsutomu, Tsuyoshi
Matsubara, Yoshihito Shima, Shigehiko Haeno, Tetsuo Fujimoto, Kenji Tone,
Nobuhiko Shibata, and Saburo Sakoda, "Neurosteroids in cerebrospinal fluid
in neurologic disorders," Journal of the Neurological Sciences, Vol. 120,
1993, pp. 87-92.
Barrett-Conner,
Elizabeth and Sharon L. Edelstein, "A Prospective Study of Dehydroepiandrosterone
Sulfate and Cognitive Function in an Older Population: The Rancho Bernardo
Study," American Geriatrics Society, Vol. 42, No. 4, April 1994, pp. 420-423.
Beer, Nusen A.,
Daniela J. Jakubowicz, Rivka M. Beer, Ildefonso R. Arocha, and John E.
Nestler, "Effects of Nitrendipine on Glucose Tolerance and Serum Insulin
and Dehydroepiandrosterone Sulfate Levels in Insulin-Resistant Obese and
Hypertensive Men," Journal of Clinical Endocrinology and Metabolism, Vol.
76, No. 1, 1993, pp. 178-183.
Carilla, E., M.
Briley, F. Fauran, et al., Binding of Permixon, “A new treatment for prostatic
benign hyperplasia, to the cytosolic androgen receptor in the rat prostate,”
J. Steroid Biochem., 20, 521-523, 1984.
De Pergola, G.,
V. A. Giagulli, G. Garruti, M. R. Cospite, F. Giorgino, M. Cignarelli,
and R. Giorgino, "Low Dehydroepiandrosterone Circulating Levels in Premenopausal
Obese Women with Very High Body Mass Index," Metabolism, Vol. 40, No.
2, February 1991, pp. 187-190.
Ensminger, Audrey
H., M. E. Ensminger, James E. Konlande, and John R.K. Robson, The Concise
Encyclopedia of Foods & Nutrition, CRC Press, Boca Raton, FL, 1995.
Greger, R., and
U. Windhorst (Editors), Comprehensive Human Physiology, Volume 1 & 2,
Springer Publishing, New York and Heidleberg, 1996.
Guton, Arthur C.,
and John E. Hall, Textbook of Medical Physiology, Ninth Edition, W.B Sanders
Company, Philadelphia, PA., 1996.
Haffner, Steven
M., Paula Karhapaa, Leena Mykkanen and Markku Laakso, "Insulin Resistance,
Body Fat Distribution, and Sex Hormones in Men," Diabetes, Vol. 43, February
1994, pp. 212-219.
Krall, Elizabeth,
A., and Bess Dawson-Hughes, Osteoporosis, in Modern Nutrition in Health
and Disease, Volumes 2, Lea & Febiger, Philadelphia, PA, 1994.
Kendrew, Sir John,
(Editor in Chief), The Encyclopedia of Molecular Biology, Blackwell Science,
New York and Oxford, 1994.
LaCroix, Andrea
Z., PhD; Katsuhiko Yano, MD; and Dwayne M. Reed, MD, PhD., "Dehydroepiandrosterone
Sulfate, Incidence of Myocardial Infarction, and Extent of Atherosclerosis
in Men," Circulation, Vol. 86, No. 5, November 1992, pp. 1529-1535.
Lehninger, Albert
L., David L. Nelson, and Michael M. Cox, Principles of Biochemistry, Worth
Publishers, New York, NY, 1993.
Leszczynski, D.
E., R. M. Schafer, E. G. Perkins, J. P. Jerrell and F. A. Kummerow, "Esterification
of Dehydroepiandrosterone by human plasma HDL" Biochimica et Biophysica
Acta, Elsevier Science Publishers B. V. (Biomedical Division), Vol. 1014,
1989, pp. 90-97.
Liu, C. H., G. A.
Laughlin, U. G. Fischer, and S. S. C. Yen, "Marked Attenuation of Ultradian
and Circadian Rhythms of Dehydroepiandrosterone in Postmenopausal Women:
Evidence for a Reduced 17, 20-Desmolase Enzymatic Activity," Journal of
Clinical Endocrinology and Metabolism, Vol. 71, No. 4, 1990, pp. 900-906.
Linder, Marcia C.,
Editor, Nutritional Biochemistry and Metabolism with Clinical Applications,
Appleton & Lange, Norwalk, CT, 1991.
Thibodeau, Gary
G., Kevin T. Patton, Anatomy & Physiology, Third Edition, Mosby St. Louis
, MO., 1996.
Pi-Sunyer, Xavier
F., Obesity, Modern Nutrition in Health and Disease, Volumes 1 and 2,
Lea & Febiger, Philadelphia, PA, 1994.
Regelson,
William and Mohammed Kalimi, “Dehrdropeiandrosterone (DHEA)-the
Multifunctional Steroid, II. Effects on the CNS, Cell Proliferation,
Metabolic and Vascular, Clinical and Other Effects. Mechanism or
Action?,” Annals New York Academy of Sciences, 1994, pp. 564-575.
Sheriff, D. S. and
M. El Fakhri, "Serum Lipoprotein and Concentration of Dehydroepiandrosterone
Sulfate (DHEAS) in Olucose-6-Phosphate Dehydrogenase- Deficient Subjects,"
Clinical Chemistry, Vol. 36, No. 2, 1990, pp. 393-394.
Shils, Maurice E.,
James A. Olson, and Moshe Shike, Modern Nutrition in Health and Disease,
Volumes 1 and 2, Lea & Febiger, Philadelphia, PA, 1994.
Tasca, A., M. Barulli,
A. Cavazzana, et al., “Treatment of obstructive symptomatology caused
by prostatic adenoma with an extract of Serenoa repens (Saw palmetto).
Double-blind clinical study vs. placebo,” Minerva Urol. Nefrol., 37, 87-91,
1985.
Voet, Donald, and
Judith G. Voet, Biochemistry, Second Edition, John Wiley & Sons, Inc.,
New York, N.Y. 1995 Weatherall, D.J., J.G.G. Ledingham, D.A. Warrell (Editors),
Oxford Textbook of Medicine, Volumes 1, 2 and 3, Oxford University Press,
Oxford, England, 1996.
Williams, Daniel
P., Thomas W. Boyden, Richard W. Pamenter, Timothy 6. Lohman, and Scott
B. Going, "Relationship of Body Fat Percentage and Fat Distribution with
Dehydroepiandrosterone Sulfate in Premenopausal Females," Journal of Clinical
Endocrinology and Metabolism, Vol. 77, No. 1, 1993, pp. 80-85.
Windhorst, U., Regulatory
Principles in Physiology, in Greger, R., and Windhorst, U., (Editors),
Comprehensive Human Physiology, Volume 1 & 2, Springer Publishing,
New York and Heidleberg, 1996. |
|
